National Center of Excellence for Pharmaceutical Process Design to be Established in the U.S.

Photo credit: Sam Moqadam on Unsplash

The Mid-Atlantic Technology, Research & Innovation Center (MATRIC) announced it will establish the Center of Excellence (CoE) for process design, defining a new standardized process development framework to streamline chemical manufacturing processes from laboratory bench through to commercial production. The initial projects will develop continuous processes for critical materials for the pharmaceutical industry currently substantially produced overseas. These new capabilities will be established as a result of the Department of Commerce’s recent Rapid Assistance (for) Coronavirus Economic Response (RACER) grant to the RAPID Manufacturing Institute, of which MATRIC is a sub-awardee.

“Today, the U.S. doesn’t have the manufacturing capability to produce some key raw materials and intermediates at scale to support our pharmaceutical industry and needs,” said MATRIC chairman and CEO Steven B. Hedrick. “The COVID pandemic and the current global supply chain issues have taught us the importance of supply chain stability and security, and this starts with critical raw materials produced domestically, distributed with purpose and efficiently accessed.” Read the complete article here.